Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Biofire Diagnostics, LLC

Approvalsdevice cleared21 Oct 2026

Biofire Diagnostics, LLC

21 Oct 2026: Device cleared · BIOFIRE SPOTFIRE Vaginitis (VG) Panel. Recorded in the openFDA device 510(k) data.

View the source record

Decided
21 Oct 2026
Device
BIOFIRE SPOTFIRE Vaginitis (VG) Panel
Specialty
Microbiology
Country
United States
Location
Salt Lake City, UT
Clearance type
Dual Track
510(k) number
K262136
Submitted
2026-06-25
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Biofire Diagnostics, LLC

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Biofire Diagnostics, LLC in our registers.

More in Microbiology

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.